FIA
SOPH icon

FNY Investment Advisers’s SOPHiA GENETICS SOPH Stock Holding History

FNY Investment Advisers’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,010
Closed -$74K – 1071
2025
Q4 		$74K Sell
16,010
-28,695
-64% -$130K 0.02% 389
2025
Q3 		$212K Buy
+44,705
New +$154K 0.07% 263
2025
Q2 		– Sell
-6,833
Closed -$22K – 1176
2025
Q1 		$22K Buy
+6,833
New +$24K 0.01% 390

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

FNY Investment Advisers's SOPH Position: Q1 2026 in Review

FNY Investment Advisers sold out of SOPHiA GENETICS (SOPH) in Q1 2026, closing a stake of 16,010 shares — an estimated $74K sold.

FNY Investment Advisers first reported a position in SOPH in Q1 2025 and held it in 3 quarters. The position peaked at $212K in Q3 2025. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • FNY Investment Advisers reported no remaining SOPHiA GENETICS position as of Q1 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 16,010 SOPHiA GENETICS shares in Q1 2026, an estimated $74K.
  • FNY Investment Advisers first reported a position in SOPHiA GENETICS in Q1 2025 and held it in 3 quarters.
  • FNY Investment Advisers's SOPHiA GENETICS position peaked at $212K in Q3 2025.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on FNY Investment Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.